baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UC WAR. CALL 06/26 LLY/ DE000HD576B6 /

07/06/2024 21:41:48	Chg.+1.440	Bid21:59:45	Ask21:59:45	Underlying	Strike price	Expiration date	Option type
25.790EUR	+5.91%	25.570 Bid Size: 2,000	25.730 Ask Size: 2,000	ELI LILLY	680.00 -	17/06/2026	Call

GlobeNewswire 06/06 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...

GlobeNewswire 06/06 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...

TeleTrader 05/06 Alphabet appoints Anat Ashkenazi as new CFO

GlobeNewswire 04/06 CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Pres...

GlobeNewswire 03/06 BIOPHTA raises 6.5 million Euros Seed Funding to transition its New Standard of Care for Eye Disease...

GlobeNewswire 03/06 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine

GlobeNewswire 30/05 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024

GlobeNewswire 30/05 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More

GlobeNewswire 24/05 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District

TeleTrader 24/05 Eli Lilly to reveal $5.3B production boost

GlobeNewswire 23/05 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit

GlobeNewswire 23/05 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...

TeleTrader 21/05 Eli Lilly's diabetes drug receives authorization in China

GlobeNewswire 16/05 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...

GlobeNewswire 16/05 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly

GlobeNewswire 16/05 HEPHAISTOS secures €10.3 M to reach the clinical stage

GlobeNewswire 15/05 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member

GlobeNewswire 13/05 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...

GlobeNewswire 09/05 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...

GlobeNewswire 09/05 Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...

GlobeNewswire 09/05 ProQR Announces First Quarter 2024 Operating and Financial Results

GlobeNewswire 08/05 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

GlobeNewswire 08/05 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...

GlobeNewswire 08/05 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO

UC WAR. CALL 06/26 LLY/ DE000HD576B6 /

If you wish to receive reply to your feedback, please provide your email address.